Stocks and Investing Stocks and Investing
Wed, October 18, 2023
Tue, October 17, 2023

Anupam Rama Maintained (SNDX) at Buy with Increased Target to $38 on, Oct 17th, 2023


Published on 2024-10-28 06:56:13 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Increased Target from $36 to $38 on, Oct 17th, 2023.

Anupam has made no other calls on SNDX in the last 4 months.



There are 9 other peers that have a rating on SNDX. Out of the 9 peers that are also analyzing SNDX, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 9 analyists that currently disagree with Anupam


  • Chris Shibutani of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Wednesday, October 11th, 2023
  • Joel Beatty of "Baird" Maintained at Buy with Decreased Target to $28 on, Tuesday, October 3rd, 2023
  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $42 on, Monday, October 2nd, 2023
  • George Farmer of "Scotiabank" Initiated at Buy and Held Target at $39 on, Thursday, July 27th, 2023
  • Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $34 on, Wednesday, July 26th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, July 26th, 2023
  • Kalpit Patel of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $36 on, Tuesday, July 25th, 2023
  • Michael Schmidt of "Guggenheim" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, July 25th, 2023
  • Justin Zelin of "BTIG" Maintained at Strong Buy with Increased Target to $35 on, Monday, June 26th, 2023
Contributing Sources